Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products 28 September 2025
Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis 11 August 2025
Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025 29 July 2025
Actoverco Showcases Cardiovascular Portfolio at the 10th Joint Iranian Congress of Cardiology and Cardiovascular Surgery 21 May 2025
Actover Pharmaceutical Group Showcases Its Neurology Portfolio at the 32nd Iranian Congress of Neurology and Clinical Electrophysiology 6 May 2025
First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment 9 March 2025
